Allcyte has been acquired by Exscientia for 60M USD, merging Exscientia’s amazing AI-driven drug discovery capabilities with Pharmacoscopy’s AI-driven personalized drug screening platform – Exciting times ahead!
Read more here:
- Exscientia acquires personalised medicine AI pioneer Allcyte (Exscientia)
- British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company (Fortune Magazine)
- Exscientia spends SoftBank’s cash in bid to edge out AI rivals (Endpoints News)
- Exscientia steps up AI-powered drug discovery with $60M Allcyte acquisition (Fierce Biotech)